Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/15/2862631/0/en/Eagle-Pharmaceuticals-to-Present-Additional-Data-from-Phase-III-Trial-Demonstrating-Sustained-Response-of-Amisulpride-for-the-Rescue-Treatment-of-Postoperative-Nausea-and-Vomiting-.html
https://www.globenewswire.com/news-release/2024/04/12/2862382/0/en/Eagle-Pharmaceuticals-Announces-Receipt-of-Notification-of-Deficiency-from-Nasdaq-Regarding-Requirement-to-Timely-File-Annual-Report-on-Form-10-K.html
https://www.prnewswire.com/news-releases/egrx-investors-have-opportunity-to-lead-eagle-pharmaceuticals-inc-securities-fraud-lawsuit-302057965.html
https://www.prnewswire.com/news-releases/egrx-investors-have-opportunity-to-lead-eagle-pharmaceuticals-inc-securities-fraud-lawsuit-302044024.html
https://www.globenewswire.com//news-release/2024/01/18/2811388/0/en/Eagle-Pharmaceuticals-Provides-Update-on-Bendamustine-Intellectual-Property-Portfolio.html
https://www.globenewswire.com/news-release/2023/12/06/2792093/0/en/Eagle-Pharmaceuticals-to-Present-Abstract-on-Post-hoc-Analysis-of-Amisulpride-at-the-77th-PGA-PostGraduate-Assembly-in-Anesthesiology-in-New-York-City.html
https://www.globenewswire.com//news-release/2023/11/29/2787654/0/en/Eagle-Pharmaceuticals-Announces-Receipt-of-Notification-of-Deficiency-from-Nasdaq-Regarding-Requirement-to-Timely-File-Quarterly-Report-on-Form-10-Q.html
https://www.globenewswire.com//news-release/2023/11/29/2787649/0/en/Eagle-Pharmaceuticals-Announces-Management-Change.html
https://www.globenewswire.com//news-release/2023/11/09/2777235/0/en/Eagle-Delays-Third-Quarter-2023-Results-and-Conference-Call.html
https://www.globenewswire.com//news-release/2023/11/08/2776254/0/en/Eagle-Pharmaceuticals-to-Host-Third-Quarter-2023-Financial-Results-on-November-9-2023.html